Presentation TCT 2025 TCT 1129: The long-term outcomes of VitaFlow transcatheter valve system in the treatment of high surgical risk patients with severe aortic stenosis(VITAL trial):bicuspid versus tricuspid valve Presenter: Shasha Chen October 26, 2025
Presentation TCT 2025 TCT 1135: Safety and efficacy of Transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type-0 bicuspid aortic valve stenosis patients Presenter: Dejing Feng October 26, 2025
Presentation TCT 2025 Featured Innovation: Automated Diagnosis and Classification of Aortic Stenosis from A Single Echocardiographic View: A Novel Machine Learning Approach Presenter: Mayooran Namasivayam October 26, 2025
Presentation TCT 2025 TCT 1140: Stent Frame Deformation of Self-Expanding TAVR in Bicuspid Aortic Stenosis and Impact on Valve Performance Presenter: Gabriela Tirado-Conte October 26, 2025
Presentation TCT 2025 Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis Presenter: Philippe Genereux October 26, 2025
Presentation TCT 2025 Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease Presenter: Gilbert H. L. Tang October 26, 2025
Presentation TCT 2025 Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat? Presenter: Matthew John Czarny October 26, 2025
Presentation TCT 2025 TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement Presenter: Jung-Joon Cha October 26, 2025
Presentation TCT 2025 Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention Presenter: Chetan Huded October 26, 2025
Presentation TCT 2025 Addressing Disparities In Aortic Stenosis Management: Have We Made Progress? Presenter: Wayne Batchelor October 26, 2025
Presentation TCT 2025 Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond Presenter: Sammy Elmariah October 26, 2025
Presentation TCT 2025 From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis Presenter: Linda D. Gillam October 26, 2025
Presentation TCT 2025 TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations Presenter: Philipp Kiefer October 26, 2025
Presentation TCT 2025 TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched Presenter: Hasnan M. Ijaz October 26, 2025
Presentation TCT 2025 TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR Presenter: Robert Kay October 26, 2025
Presentation TCT 2025 TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study Presenter: Shayan Khan October 26, 2025
Presentation TCT 2025 TAVR Device Selection Considerations (SMART) Presenter: Howard C. Herrmann October 26, 2025
Presentation TCT 2025 SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA) Presenter: Marvin H. Eng October 26, 2025
Presentation TCT 2025 Small Annulus Definitions, Misconceptions, and the Great Divide Presenter: Rebecca T. Hahn October 26, 2025
Presentation TCT 2025 The “Reality” of Surgical Aortic Root Enlargement Presenter: Bo Yang October 26, 2025